Shenzhen Bioeasy Biotechnology Co., Ltd. Stock
Equities
300942
CNE100004C78
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.22 CNY | -1.44% | +8.30% | -29.68% |
Sales 2022 | 687M 95.09M | Sales 2023 | 254M 35.18M | Capitalization | 4.69B 649M |
---|---|---|---|---|---|
Net income 2022 | 83M 11.49M | Net income 2023 | -185M -25.61M | EV / Sales 2022 | 9.55 x |
Net cash position 2022 | 310M 42.92M | Net cash position 2023 | 236M 32.66M | EV / Sales 2023 | 17.5 x |
P/E ratio 2022 |
81.6
x | P/E ratio 2023 |
-25.4
x | Employees | 635 |
Yield 2022 |
0.12% | Yield 2023 |
-
| Free-Float | 22.42% |
1 day | -1.44% | ||
1 week | +8.30% | ||
Current month | +8.30% | ||
1 month | +0.61% | ||
3 months | +27.84% | ||
6 months | -35.33% | ||
Current year | -29.68% |
Managers | Title | Age | Since |
---|---|---|---|
Zhao Li Xiao
CEO | Chief Executive Officer | 50 | 22-07-28 |
Kai Wan
DFI | Director of Finance/CFO | 42 | 21-12-26 |
Mei Xia Li
CHM | Chairman | 36 | 12-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Fu
BRD | Director/Board Member | 40 | 08-02-29 |
Xi Li Wang
BRD | Director/Board Member | 39 | 10-06-30 |
Mei Xia Li
CHM | Chairman | 36 | 12-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 8.22 | -1.44% | 10,689,080 |
24-05-08 | 8.34 | +5.30% | 13,922,400 |
24-05-07 | 7.92 | +0.38% | 4,007,523 |
24-05-06 | 7.89 | +3.95% | 4,655,600 |
End-of-day quote Shenzhen S.E., May 08, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-29.68% | 456M | |
-0.10% | 12.64B | |
-1.64% | 8.37B | |
+0.43% | 5.37B | |
+22.42% | 5.26B | |
-0.09% | 4.58B | |
-52.84% | 3.16B | |
+20.02% | 2.89B | |
-8.27% | 2.22B | |
-2.45% | 1.91B |
- Stock Market
- Equities
- 300942 Stock